top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.450 -0.010 (-0.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 580,741
Open 2.480
Bid (Size) 2.300 (100)
Ask (Size) 2.500 (100)
Prev. Close 2.460
Today's Range 2.410 - 2.515
52wk Range 1.330 - 2.530
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
+25.6%
+25.6%
1 Month
+25.0%
+25.0%
3 Month
+20.7%
+20.7%
6 Month
+48.5%
+48.5%
1 Year
+62.3%
+62.3%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 2.450
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 08/11/26 04:00 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 76.09M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 76M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
bottom of page